Iron and cancer: more ore to be mined

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

Cancer-related inflammation

Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399 · see citing works

Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1

Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836 · see citing works

Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization

Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · see citing works

Cell cycle, CDKs and cancer: a changing paradigm

Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957 · see citing works

Anemia of Chronic Disease

Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800 · see citing works

Nuclear factor-κB in cancer development and progression

Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519 · see citing works

Wnt signaling and cancer

Polakis, P. (2000) · Genes & Development · doi:10.1101/gad.14.15.1837 · Cited by 3,183 · see citing works

Curcumin: From ancient medicine to current clinical trials

Hatcher, H., Planalp, R. P., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,847 · see citing works

HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression

Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693 · see citing works

Wnt signalling and its impact on development and cancer

Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595 · see citing works

HIF-1: upstream and downstream of cancer metabolism

Semenza, G. L. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.10.009 · Cited by 1,381 · see citing works

Hepcidin and iron homeostasis

Ganz, T., & Nemeth, E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.01.014 · Cited by 1,282 · see citing works

Survival and Causes of Death in Cirrhotic and in Noncirrhotic Patients with Primary Hemochromatosis

Niederau, C., Fischer, R., Sonnenberg, A., Stremmel, W., Trampisch, H. J., & Strohmeyer, G. W. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511143132004 · Cited by 1,063 · see citing works

Regulation of Mitochondrial Iron Accumulation by Yfh1p, a Putative Homolog of Frataxin

Babcock, M., de Silva, D., Oaks, R., Davis-Kaplan, S., Jiralerspong, S., Montermini, L., Pandolfo, M., & Kaplan, J. (1997) · Science · doi:10.1126/science.276.5319.1709 · Cited by 921 · see citing works

A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage

Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., & Nakamura, Y. (2000) · Nature · doi:10.1038/35003506 · Cited by 904 · see citing works

Serum ferritin: Past, present and future

Wang, W., Knovich, M. A., Coffman, L. G., Torti, F. M., & Torti, S. V. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.03.011 · Cited by 882 · see citing works

Iron withholding: a defense against infection and neoplasia

Weinberg, E. D. (1984) · Physiological Reviews · doi:10.1152/physrev.1984.64.1.65 · Cited by 881 · see citing works

The transferrin receptor and the targeted delivery of therapeutic agents against cancer

Daniels, T. R., Bernabeu, E., Rodríguez, J. A., Patel, S., Kozman, M., Chiappetta, D. A., Holler, E., Ljubimova, J. Y., Helguera, G., & Penichet, M. L. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.07.016 · Cited by 807 · see citing works

Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia

Lee, P. J., Jiang, B.-H., Chin, B. Y., Iyer, N. V., Alam, J., Semenza, G. L., & Choi, A. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5375 · Cited by 782 · see citing works

Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells

Ohgami, R. S., Campagna, D. R., Greer, E. L., Antiochos, B., McDonald, A., Chen, J., Sharp, J. J., Fujiwara, Y., Barker, J. E., & Fleming, M. D. (2005) · Nature Genetics · doi:10.1038/ng1658 · Cited by 775 · see citing works

Desferrioxamine induces erythropoietin gene expression and hypoxia- inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction

Wang, G., & Semenza, G. (1993) · Blood · doi:10.1182/blood.v82.12.3610.3610 · Cited by 766 · see citing works

Mechanisms of free radical-induced damage to DNA

Dizdaroğlu, M., & Jaruga, P. (2012) · Free Radical Research · doi:10.3109/10715762.2011.653969 · Cited by 748 · see citing works

Ferritin heavy chain upregulation by NF-κB inhibits TNFα-induced apoptosis by suppressing reactive oxygen species

Pham, C. G., Bubici, C., Zazzeroni, F., Papa, S., Jones, J., Alvarez, K., Jayawardena, S., De Smaele, E., Cong, R., Beaumont, C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.10.017 · Cited by 663 · see citing works

Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)

Peyssonnaux, C., Zinkernagel, A. S., Schuepbach, R. A., Rankin, E., Vaulont, S., Haase, V. H., Nizet, V., & Johnson, R. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31370 · Cited by 639 · see citing works

Forging a field: the golden age of iron biology.

Andrews, N. C. (2008) · Blood · doi:10.1182/blood-2007-12-077388 · Cited by 623 · see citing works

Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment

Pietrangelo, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.013 · Cited by 615 · see citing works

Body Iron Stores and the Risk of Cancer

Stevens, R. G., Jones, D. Y., Micozzi, M. S., & Taylor, P. R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810203191603 · Cited by 576 · see citing works

Binding and uptake of H-ferritin are mediated by human transferrin receptor-1

Li, L., Fang, C. J., Ryan, J. C., Niemi, E. C., Lebrón, J. A., Björkman, P. J., Arase, H., Torti, F. M., Torti, S. V., Nakamura, M. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913192107 · Cited by 558 · see citing works

A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics

Whitnall, M., Howard, J., Ponka, P., & Richardson, D. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604979103 · Cited by 510 · see citing works

HIF-2α, but not HIF-1α, promotes iron absorption in mice

Mastrogiannaki, M., Matak, P., Keith, B., Simon, M. C., Vaulont, S., & Peyssonnaux, C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38499 · Cited by 502 · see citing works

The role of mitochondria in cellular iron–sulfur protein biogenesis and iron metabolism

Lill, R., Hoffmann, B., Molik, S., Pierik, A. J., Rietzschel, N., Stehling, O., Uzarska, M. A., Webert, H., Wilbrecht, C., & Mühlenhoff, U. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.009 · Cited by 501 · see citing works

Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway

Cohen, L. A., Gutierrez, L., Weiss, A., Leichtmann-Bardoogo, Y., Zhang, D.-L., Crooks, D. R., Sougrat, R., Morgenstern, A., Galy, B., Hentze, M. W., et al. (2010) · Blood · doi:10.1182/blood-2009-11-253815 · Cited by 452 · see citing works

Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis

Pinnix, Z. K., Miller, L. D., Wang, W., D’Agostino, R., Kute, T., Willingham, M. C., Hatcher, H., Tesfay, L., Sui, G., Di, X., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001127 · Cited by 448 · see citing works

Differential regulation of iron homeostasis during human macrophage polarized activation

Recalcati, S., Locati, M., Marini, A., Santambrogio, P., Zaninotto, F., De Pizzol, M., Zammataro, L., Girelli, D., & Cairo, G. (2010) · European Journal of Immunology · doi:10.1002/eji.200939889 · Cited by 438 · see citing works

Microbial siderophores: a mini review

Saha, R., Saha, N., Donofrio, R. S., & Bestervelt, L. L. (2012) · Journal of Basic Microbiology · doi:10.1002/jobm.201100552 · Cited by 438 · see citing works

Intestinal Hypoxia-Inducible Transcription Factors Are Essential for Iron Absorption following Iron Deficiency

Shah, Y. M., Matsubara, T., Ito, S., Yim, S.-H., & Gonzalez, F. J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.12.012 · Cited by 431 · see citing works

Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: Implications for regulation and cellular function

Hubert, N., & Hentze, M. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192423399 · Cited by 428 · see citing works

Mitochondrial Dysfunction Leads to Nuclear Genome Instability via an Iron-Sulfur Cluster Defect

Veatch, J. R., McMurray, M. A., Nelson, Z. W., & Gottschling, D. E. (2009) · Cell · doi:10.1016/j.cell.2009.04.014 · Cited by 427 · see citing works

TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23)

Lorsbach, R. B., Moore, J., Mathew, S., Raimondi, S. C., Mukatira, S. T., & Downing, J. R. (2003) · Leukemia · doi:10.1038/sj.leu.2402834 · Cited by 416 · see citing works

Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents

Adams, B. K., Ferstl, E. M., Davis, M. C., et al. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.05.006 · Cited by 392 · see citing works

Eukaryotic DNA polymerases require an iron-sulfur cluster for the formation of active complexes

Netz, D. J. A., Stith, C. M. W., Stümpfig, M., Köpf, G., Vogel, D., Genau, H. M., Stodola, J. L., Lill, R., Burgers, P., & Pierik, A. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.721 · Cited by 388 · see citing works

Untitled work

(2003) · PubMed · Cited by 381 · see citing works

Identification of a hypoxia response element in the transferrin receptor gene

Lok, C. N., & Ponka, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24147 · Cited by 380 · see citing works

Transferrin Receptor Induction by Hypoxia

Tacchini, L., Bianchi, L., Bernelli-Zazzera, A., & Cairo, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24142 · Cited by 379 · see citing works

Ferroportin-mediated iron transport: Expression and regulation

Ward, D. M., & Kaplan, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.03.004 · Cited by 373 · see citing works

RTEL1 Maintains Genomic Stability by Suppressing Homologous Recombination

Barber, L. J., Youds, J. L., Ward, J. D., McIlwraith, M. J., O'Neil, N. J., Petalcorin, M. I. R., Martin, J. S., Collis, S. J., Cantor, S. B., Auclair, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.08.016 · Cited by 369 · see citing works

Dietary Supplements and Mortality Rate in Older Women

Mursu, J. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.445 · Cited by 339 · see citing works

The DNA Repair Helicases XPD and FancJ Have Essential Iron-Sulfur Domains

Rudolf, J., Makrantoni, V., Ingledew, W. J., Stark, M. J. R., & White, M. F. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.07.019 · Cited by 330 · see citing works

Coordinated Regulation of Iron-Controlling Genes, H-Ferritin and IRP2 , by c-MYC

Wu, K., Polack, A., & Dalla‐Favera, R. (1999) · Science · doi:10.1126/science.283.5402.676 · Cited by 328 · see citing works

Body iron stores and risk of cancer

Knekt, P., Reunanen, A., Takkunen, H., Aromaa, A., Heliövaara, M., & Hakuunen, T. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560315 · Cited by 314 · see citing works

Iron traffics in circulation bound to a siderocalin (Ngal)–catechol complex

Bao, G., Clifton, M., Hoette, T. M., Mori, K., Deng, S.-X., Qiu, A., Viltard, M., Williams, D., Paragas, N., Leete, T., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.402 · Cited by 307 · see citing works

Polarization dictates iron handling by inflammatory and alternatively activated macrophages

Corna, G., Campana, L., Pignatti, E., Castiglioni, A., Tagliafico, E., Bosurgi, L., Campanella, A., Brunelli, S., Manfredi, A. A., Apostoli, P., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.023879 · Cited by 304 · see citing works

Ferritin functions as a proinflammatory cytokine via iron‐independent protein kinase C zeta/nuclear factor kappaB–regulated signaling in rat hepatic stellate cells†

Ruddell, R. G., Hoang‐Le, D., Barwood, J. M., Rutherford, P. S., Piva, T. J., Watters, D. J., Santambrogio, P., Arosio, P., & Ramm, G. A. (2009) · Hepatology · doi:10.1002/hep.22716 · Cited by 298 · see citing works

The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene.

Torti, S. V., Kwak, E. L., Miller, S. C., Miller, L. L., Ringold, G. M., Myambo, K. B., Young, A. P., & Torti, F. M. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37801-3 · Cited by 295 · see citing works

A Mammalian Siderophore Synthesized by an Enzyme with a Bacterial Homolog Involved in Enterobactin Production

Devireddy, L. R., Hart, D. O., Goetz, D. H., & Green, M. R. (2010) · Cell · doi:10.1016/j.cell.2010.04.040 · Cited by 295 · see citing works

Iron-regulatory proteins limit hypoxia-inducible factor-2α expression in iron deficiency

Sanchez, M., Galy, B., Muckenthaler, M. U., & Hentze, M. W. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1222 · Cited by 294 · see citing works

MMS19 Assembles Iron-Sulfur Proteins Required for DNA Metabolism and Genomic Integrity

Stehling, O., Vashisht, A. A., Mascarenhas, J., Jónsson, Z. O., Sharma, T., Netz, D. J. A., Pierik, A. J., Wohlschlegel, J. A., & Lill, R. (2012) · Science · doi:10.1126/science.1219723 · Cited by 291 · see citing works

The N‐myc downstream regulated gene (NDRG) family: diverse functions, multiple applications

Melotte, V., Qu, X., Ongenaert, M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-151464 · Cited by 285 · see citing works

The Matrix Metalloproteinase-9/Neutrophil Gelatinase-Associated Lipocalin Complex Plays a Role in Breast Tumor Growth and Is Present in the Urine of Breast Cancer Patients

Fernández, C. A., Li, Y., Louis, G. W., Yang, J., Kutok, J. L., & Moses, M. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2391 · Cited by 283 · see citing works

Moderate elevation of body iron level and increased risk of cancer occurrence and death

Stevens, R. G., Graubard, B. I., Micozzi, M. S., Neriishi, K., & Blumberg, B. S. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560312 · Cited by 276 · see citing works

Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency

Mukhopadhyay, C. K., Mazumder, B., & Fox, P. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000636200 · Cited by 274 · see citing works

Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives

Elmberg, M., Hultcrantz, R., Ekbom, A., Brandt, L., Olsson, S., Olsson, R., Lindgren, S., Lööf, L., Stål, P., Wallerstedt, S., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.035 · Cited by 273 · see citing works

Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator

Jiao, Y., Wilkinson, J., Di, X., Wang, W., Hatcher, H., Kock, N. D., D'Agostino, R., Knovich, M. A., Torti, F. M., & Torti, S. V. (2009) · Blood · doi:10.1182/blood-2008-05-155952 · Cited by 266 · see citing works

The Iron Chelators Dp44mT and DFO Inhibit TGF-β-induced Epithelial-Mesenchymal Transition via Up-Regulation of N-Myc Downstream-regulated Gene 1 (NDRG1)

Chen, Z., Zhang, D., Yue, F., Zheng, M., Kovačević, Ž., & Richardson, D. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.350470 · Cited by 250 · see citing works

Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non–iron-related chronic liver disease

Fracanzani, A. L. (2001) · Hepatology · doi:10.1053/jhep.2001.22506 · Cited by 246 · see citing works

Damage to the DNA bases in mammalian chromatin by hydrogen peroxide in the presence of ferric and cupric ions

Dizdaroglu, M., Rao, G., Halliwell, B. B., & Gajewski, E. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90366-q · Cited by 244 · see citing works

Synthetic and natural iron chelators: Therapeutic potential and clinical use

Hatcher, H. C., Singh, R. N., Torti, F. M., & Torti, S. V. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.121 · Cited by 242 · see citing works

Overexpression of Wild Type and Mutated Human Ferritin H-chain in HeLa Cells

Cozzi, A., Corsi, B., Levi, S., Santambrogio, P., Albertini, A., & Arosio, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003797200 · Cited by 242 · see citing works

Modulation of iron transport proteins in human colorectal carcinogenesis

Brookes, M. J., Hughes, S., Turner, F. E., Reynolds, G., Sharma, N., Ismail, T., Berx, G., McKie, A. T., Hotchin, N., Anderson, G. J., et al. (2006) · Gut · doi:10.1136/gut.2006.094060 · Cited by 226 · see citing works

Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer

Bauer, M., Eickhoff, J. C., Gould, M. N., Mundhenke, C., Maass, N., & Friedl, A. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9619-3 · Cited by 215 · see citing works

The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels

Tong, W.-H., Sourbier, C., Kovtunovych, G., Jeong, S. Y., Vira, M., Ghosh, M., Romero, V. V., Sougrat, R., Vaulont, S., Viollet, B., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.07.018 · Cited by 212 · see citing works

Iron chelation in the biological activity of curcumin

Jiao, Y., Wilkinson, J. C., Pietsch, E. C., Buss, J. L., Wang, W., Planalp, R. P., Torti, F. M., & Torti, S. V. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.11.003 · Cited by 211 · see citing works

Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults

Wu, T., Sempos, C. T., Freudenheim, J. L., Muti, P., & Smit, E. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00119-4 · Cited by 211 · see citing works

Role of ferritin alterations in human breast cancer cells

Shpyleva, S., Tryndyak, V., Kovalchuk, O., Starlard‐Davenport, A., Chekhun, V. F., Beland, F. A., & Pogribny, I. P. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0849-4 · Cited by 206 · see citing works

An iron regulatory gene signature predicts outcome in breast cancer

Miller, L. D., Coffman, L. G., Chou, J. W., Black, M. A., Bergh, J., D'Agostino, R., Torti, S. V., & Torti, F. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1870 · Cited by 202 · see citing works

Induction of Oxidative Metabolism by Mitochondrial Frataxin Inhibits Cancer Growth

Schulz, T. J., Thierbach, R., Voigt, A., Drewes, G., Mietzner, B., Steinberg, P., Pfeiffer, A. F. H., & Ristow, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511064200 · Cited by 198 · see citing works

Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum

Galy, B., Ferring-Appel, D., Kaden, S., Gröne, H.-J., & Hentze, M. W. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.006 · Cited by 195 · see citing works

Cohort Study of Internal Malignancy in Genetic Hemochromatosis and Other Chronic Nonalcoholic Liver Diseases 2

Bradbear, R. A., Bain, C. J., Siskind, V., Schofield, F. D., Webb, S. I., Axelsen, E., Halliday, J. W., Bassett, M. L., & Powell, L. W. (1985) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/75.1.81 · Cited by 195 · see citing works

Hydroxyl radical production and human DNA damage induced by ferric nitrilotriacetate and hydrogen peroxide.

Inoue, S., & Kawanishi, S. (1987) · PubMed · Cited by 194 · see citing works

Nephrotoxicity and Renal Cell Carcinoma After Use of Iron- and Aluminum-Nitrilotriacetate Complexes in Rats 2

Ebina, Y., Okada, S., Hamazaki, S., Ogino, F., Li, J., & Midorikawa, O. (1986) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/76.1.107 · Cited by 194 · see citing works

Role for NF-κB in the regulation of ferritin H by tumor necrosis factor-α

Kwak, E. L., Larochelle, D. A., Beaumont, C., Torti, S. V., & Torti, F. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15285 · Cited by 189 · see citing works

Iron Chelators for the Treatment of Cancer

Yu, Y., Gutierrez, E., Kovačević, Ž., Saletta, F., Obeidy, P., Rahmanto, Y. S., & Richardson, D. R. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800609706 · Cited by 188 · see citing works

In vitro and in vivo effects of deferoxamine in neonatal acute leukemia

Estrov, Z., Tawa, A., Wang, X., Dube, I., Sulh, H., Cohen, A., Gelfand, E. W., & Freedman, M. H. (1987) · Blood · doi:10.1182/blood.v69.3.757.757 · Cited by 187 · see citing works

Continual presence of oxygen and iron required for mammalian ribonucleotide reduction: Possible regulation mechanism

Thelander, L., Gräslund, A., & Thelander, M. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)91040-9 · Cited by 187 · see citing works

Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate.

Li, J., Okada, S., Hamazaki, S., Ebina, Y., & Midorikawa, O. (1987) · PubMed · Cited by 183 · see citing works

Dietary Iron Supplementation Enhances DSS-Induced Colitis and Associated Colorectal Carcinoma Development in Mice

Seril, D. N., Liao, J., Ho, K.-L. K., Warsi, A., Yang, C. S., & Yang, G.-Y. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1015362228659 · Cited by 183 · see citing works

Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells

Eberhard, Y., McDermott, S., Wang, X., Gronda, M., Venugopal, A. L., Wood, T. E., Hurren, R., Datti, A., Batey, R. A., Wrana, J. L., et al. (2009) · Blood · doi:10.1182/blood-2009-03-209965 · Cited by 183 · see citing works

Induction of Sarcoma in the Rat by Iron--Dextran Complex

Richmond, H. G. (1959) · BMJ · doi:10.1136/bmj.1.5127.947 · Cited by 181 · see citing works

Iron and Colorectal Cancer Risk: Human Studies

Nelson, R. L. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2001.tb07002.x · Cited by 181 · see citing works

Novel Thiosemicarbazone Iron Chelators Induce Up-Regulation and Phosphorylation of the Metastasis Suppressor N-myc Down-Stream Regulated Gene 1: A New Strategy for the Treatment of Pancreatic Cancer

Kovačević, Ž., Chikhani, S., Lovejoy, D. B., & Richardson, D. R. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073627 · Cited by 178 · see citing works

Antitumor Agents. 250. Design and Synthesis of New Curcumin Analogues as Potential Anti-Prostate Cancer Agents

Li, L., Shi, Q., Nyarko, A. K., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051043z · Cited by 175 · see citing works

DNA base modifications in renal chromatin of wistar rats treated with a renal carcinogen, ferric nitrilotriacetate

Toyokuni, S., Mori, T., & Dizdaroğlu, M. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570122 · Cited by 175 · see citing works

Deferoxamine for Advanced Hepatocellular Carcinoma

Yamasaki, T., Terai, S., & Sakaida, I. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1105726 · Cited by 172 · see citing works

Regulatory effects of ferritin on angiogenesis

Coffman, L. G., Parsonage, D., D'Agostino, R., Torti, F. M., & Torti, S. V. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812010106 · Cited by 168 · see citing works

Steap Proteins: Implications for Iron and Copper Metabolism

Knutson, M. D. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00311.x · Cited by 165 · see citing works

A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells

Ma, B. B. Y., Goh, B. C., Tan, E. H., Lam, K. C., Soo, R. A., Leong, S. S., Wang, L. Z., Mo, F. K. F., Chan, A. T. �., Zee, B. C.-Y., et al. (2007) · Investigational New Drugs · doi:10.1007/s10637-007-9085-0 · Cited by 158 · see citing works

Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice.

Hann, H. W., Stahlhut, M. W., & Blumberg, B. S. (1988) · PubMed · Cited by 157 · see citing works

Clinically overt hereditary hemochromatosis in Denmark 1948–1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients

Milman, N. T., Pedersen, P. L., Steig, T. Á., Byg, K., Graudal, N. A., & Fenger, K. (2001) · Annals of Hematology · doi:10.1007/s002770100371 · Cited by 155 · see citing works

Phase II study of Triapine® in patients with metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161)

Knox, J. J., Hotte, S. J., Kollmannsberger, C., Winquist, E., Fisher, B., & Eisenhauer, E. A. (2007) · Investigational New Drugs · doi:10.1007/s10637-007-9044-9 · Cited by 153 · see citing works

Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages

Alkhateeb, A. A., Han, B., & Connor, J. R. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2405-x · Cited by 153 · see citing works

Iron chelation regulates cyclin D1 expression via the proteasome: a link to iron deficiency–mediated growth suppression

Nurtjahja-Tjendraputra, E., Fu, D., Phang, J. M., & Richardson, D. R. (2006) · Blood · doi:10.1182/blood-2006-10-047753 · Cited by 151 · see citing works

Wnt Inhibitor Screen Reveals Iron Dependence of β-Catenin Signaling in Cancers

Song, S., Christova, T. Y., Perusini, S. J., Alizadeh, S., Bao, R.-Y., Miller, B. W., Hurren, R., Jitkova, Y., Gronda, M., Isaac, M. B., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2745 · Cited by 151 · see citing works

Hypoxia-Inducible Factor-2α Activation Promotes Colorectal Cancer Progression by Dysregulating Iron Homeostasis

Xue, X., Taylor, M. J., Anderson, E. R., Hao, C., Qu, A., Greenson, J. K., Zimmermann, E. M., Gonzalez, F. J., & Shah, Y. M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3836 · Cited by 146 · see citing works

Cancer risk following primary hemochromatosis: A population‐based cohort study in Denmark

Hsing, A. W., McLaughlin, J. K., Olsen, J. H., Mellemkjar, L., Wacholder, S., & Fraumeni, J. F. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600204 · Cited by 145 · see citing works

HFE C282Y homozygotes are at increased risk of breast and colorectal cancer†

Osborne, N. J., Gurrin, L. C., Allen, K. J., Constantine, C. C., Delatycki, M. B., McLaren, C. E., Gertig, D. M., Anderson, G. J., Southey, M. C., Olynyk, J. K., et al. (2009) · Hepatology · doi:10.1002/hep.23448 · Cited by 144 · see citing works

The Iron Chelator, Deferasirox, as a Novel Strategy for Cancer Treatment: Oral Activity Against Human Lung Tumor Xenografts and Molecular Mechanism of Action

Lui, G. Y. L., Obeidy, P., Ford, S., Tselepis, C., Sharp, D. M., Jansson, P. J., Kalinowski, D. S., Kovačević, Ž., Lovejoy, D. B., & Richardson, D. R. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.081893 · Cited by 140 · see citing works

A role for iron in Wnt signalling

Brookes, M. J., Boult, J., Roberts, K., Cooper, B. T., Hotchin, N. A., Matthews, G., Iqbal, T., & Tselepis, C. (2008) · Oncogene · doi:10.1038/sj.onc.1210711 · Cited by 139 · see citing works

Mechanism of inhibition of mammalian ribonucleotide reductase by the iron chelate of 1-formylisoquinoline thiosemicarbazone. Destruction of the tyrosine free radical of the enzyme in an oxygen-requiring reaction.

Thelander, L., & Gräslund, A. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32582-1 · Cited by 135 · see citing works

Analysis of the biologic functions of H- and L-ferritins in HeLa cells by transfection with siRNAs and cDNAs: evidence for a proliferative role of L-ferritin

Cozzi, A., Corsi, B., Levi, S., Santambrogio, P., Biasiotto, G., & Arosio, P. (2004) · Blood · doi:10.1182/blood-2003-06-1842 · Cited by 132 · see citing works

In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2

Maes, K., Nemeth, E., Roodman, G. D., Huston, A., Esteve, F., Freytes, C., Callander, N., Katodritou, E., Tussing-Humphreys, L., Rivera, S., et al. (2010) · Blood · doi:10.1182/blood-2010-03-274571 · Cited by 132 · see citing works

Overexpression of Cellular Iron Import Proteins Is Associated with Malignant Progression of Esophageal Adenocarcinoma

Boult, J. K. R., Roberts, K., Brookes, M., Hughes, S., Bury, J. P., Cross, S. S., Anderson, G. J., Spychal, R., Iqbal, T. H., & Tselepis, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1054 · Cited by 132 · see citing works

Luminal iron levels govern intestinal tumorigenesis after Apc loss in vivo

Radulescu, S., Brookes, M. J., Salgueiro, P., Ridgway, R. A., McGhee, E., Anderson, K., Ford, S. J., Stones, D. H., Iqbal, T. H., Tselepis, C., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.07.003 · Cited by 130 · see citing works

Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice

Thierbach, R., Schulz, T. J., Isken, F., Voigt, A., Mietzner, B., Drewes, G., von Kleist-Retzow, J.-C., Wiesner, R. J., Magnuson, M. A., Puccio, H., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi410 · Cited by 127 · see citing works

Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer

Yang, J., McNeish, B. L., Butterfield, C., & Moses, M. A. (2012) · The FASEB Journal · doi:10.1096/fj.12-211730 · Cited by 125 · see citing works

Iron intake, oxidative stress-related genes ( MnSOD and MPO ) and prostate cancer risk in CARET cohort

Choi, J., Neuhouser, M. L., Barnett, M. J., Hong, C., Kristal, A. R., Thornquist, M. D., King, I. B., Goodman, G. E., & Ambrosone, C. B. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn056 · Cited by 121 · see citing works

Ectopic expression of neutrophil gelatinase‐associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells

Lee, H., Lee, E., Lee, K.-J., Hong, S. W., Yoon, Y., & Kim, J. (2005) · International Journal of Cancer · doi:10.1002/ijc.21657 · Cited by 118 · see citing works

Effect of Iron and Desferoxamine on Cell Growth And In Vitro Ferritin Synthesis in Human Hepatoma Cell Lines

Hann, H. L., Stahlhut, M. W., & Hann, C. L. (1990) · Hepatology · doi:10.1002/hep.1840110407 · Cited by 114 · see citing works

Iron Metabolism

Crichton, R. R. (2009) · Wiley eBooks · doi:10.1002/9780470010303 · Cited by 111 · see citing works

Anemia in Hodgkin's Lymphoma: The Role of Interleukin-6 and Hepcidin

Hohaus, S., Massini, G., Giachelia, M., Vannata, B., Bozzoli, V., Cuccaro, A., D'Alo', F., Larocca, L. M., Raymakers, R. A. P., Swinkels, D. W., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.6873 · Cited by 110 · see citing works

Cellular Iron Depletion Stimulates the JNK and p38 MAPK Signaling Transduction Pathways, Dissociation of ASK1-Thioredoxin, and Activation of ASK1

Yu, Y., & Richardson, D. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.225946 · Cited by 107 · see citing works

Bp44mT: an orally active iron chelator of the thiosemicarbazone class with potent anti‐tumour efficacy

Yu, Y., Rahmanto, Y. S., & Richardson, D. R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01526.x · Cited by 106 · see citing works

The antitumor activity of the fungicide ciclopirox

Zhou, H., Shen, T., Luo, Y., Liu, L., Chen, W., Xu, B., Han, X., Pang, J., Rivera, C. A., & Huang, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25255 · Cited by 106 · see citing works

Crystal Structure of Human Pirin

Pang, H., Bartlam, M. G., Zeng, Q., Miyatake, H., Hisano, T., Miki, K., Wong, L., Gao, G. F., & Rao, Z. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310022200 · Cited by 105 · see citing works

Iron Deprivation Inhibits Cyclin-Dependent Kinase Activity and Decreases Cyclin D/CDK4 Protein Levels in Asynchronous MDA-MB-453 Human Breast Cancer Cells

Kulp, K. S., Green, S. L., & Vulliet, P. R. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0343 · Cited by 103 · see citing works

Fenton reaction induced cancer in wild type rats recapitulates genomic alterations observed in human cancer

Akatsuka, S., Yamashita, Y., Ohara, H., Liu, Y.-T., Izumiya, M., Abe, K., Ochiai, M., Jiang, L., Nagai, H., Okazaki, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043403 · Cited by 102 · see citing works

A systems biology view of cancer

Laubenbacher, R., Hower, V., Jarrah, A. S., Torti, S. V., Shulaev, V., Mendes, P., Torti, F. M., & Akman, S. A. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.06.001 · Cited by 101 · see citing works

Tumor Cell Cytotoxicity of a Novel Metal Chelator

Torti, S. V., Torti, F. M., Whitman, S. P., Brechbiel, M. W., Park, G., & Planalp, R. P. (1998) · Blood · doi:10.1182/blood.v92.4.1384 · Cited by 98 · see citing works

DNA2 and EXO1 in replication-coupled, homology-directed repair and in the interplay between HDR and the FA/BRCA network

Karanja, K. K., Cox, S. W., Duxin, J. P., Stewart, S. A., & Campbell, J. L. (2012) · Cell Cycle · doi:10.4161/cc.22215 · Cited by 98 · see citing works

Disruption of the <i>Lcn2</i> gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis

Berger, T., Cheung, C. C., Elia, A. J., & Mak, T. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000101107 · Cited by 96 · see citing works

Genetic Variability in Iron-Related Oxidative Stress Pathways (Nrf2, NQ01, NOS3, andHO-1), Iron Intake, and Risk of Postmenopausal Breast Cancer

Hong, C., Ambrosone, C. B., Ahn, J., Choi, J., McCullough, M. L., Stevens, V. L., Rodriguez, C., Thun, M. J., & Calle, E. E. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0247 · Cited by 95 · see citing works

Iron Uptake Mediated by Binding of H-Ferritin to the TIM-2 Receptor in Mouse Cells

Han, J., Seaman, W. E., Di, X., Wang, W., Willingham, M. C., Torti, F. M., & Torti, S. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023800 · Cited by 93 · see citing works

In Vitro Characterization of Enzymatic Properties and Inhibition of the p53R2 Subunit of Human Ribonucleotide Reductase

Shao, J., Zhou, B., Zhu, L., Qiu, W., Yuan, Y., Xi, B., & Yen, Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3048 · Cited by 93 · see citing works

A general map of iron metabolism and tissue-specific subnetworks

Hower, V., Mendes, P., Torti, F. M., Laubenbacher, R., Akman, S. A., Shulaev, V., & Torti, S. V. (2009) · Molecular BioSystems · doi:10.1039/b816714c · Cited by 92 · see citing works

Donation Frequency, Iron Loss, and Risk of Cancer Among Blood Donors

Edgren, G., Reilly, M., Hjalgrim, H., Tran, T. N., Rostgaard, K., Adami, J., Titlestad, K. E., Shanwell, A., Melbye, M., & Nyrén, O. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn084 · Cited by 91 · see citing works

Post-transcriptional Modulation of Iron Homeostasis during p53-dependent Growth Arrest

Zhang, F., Wang, W., Tsuji, Y., Torti, S. V., & Torti, F. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806432200 · Cited by 90 · see citing works

Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas.

Jiang, X. P., Elliott, R. L., & Head, J. F. (2010) · PubMed · Cited by 89 · see citing works

A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer

Yen, Y., Margolin, K. A., Doroshow, J. H., Fishman, M., Johnson, B. L., Clairmont, C., Sullivan, D., & Sznol, M. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0821-2 · Cited by 89 · see citing works

Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study

Jézéquel, P., Campion, L., Spyratos, F., Loussouarn, D., Campone, M., Guérin‐Charbonnel, C., Joalland, M., André, J., Descotes, F., Grenot, C., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26397 · Cited by 85 · see citing works

p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelator

Abeysinghe, R. D. (2001) · Carcinogenesis · doi:10.1093/carcin/22.10.1607 · Cited by 83 · see citing works

Trace Element Transport in the Mammary Gland

Lönnerdal, B. L. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093809 · Cited by 81 · see citing works

Frataxin promotes antioxidant defense in a thiol-dependent manner resulting in diminished malignant transformation in vitro

Shoichet, S. A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.7.815 · Cited by 78 · see citing works

Activation of Caspase Pathways during Iron Chelator-mediated Apoptosis

Greene, B. T., Thorburn, J., Willingham, M. C., Thorburn, A. M., Planalp, R. P., Brechbiel, M. W., Jennings‐Gee, J. E., Wilkinson, J. C., Torti, F. M., & Torti, S. V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110345200 · Cited by 77 · see citing works

Non-genotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylome

Thomson, J. P., Lempiäinen, H., Hackett, J. A., Nestor, C. E., Müller, A., Bolognani, F., Oakeley, E. J., Schübeler, D., Terranova, R., Reinhardt, D., et al. (2012) · Genome biology · doi:10.1186/gb-2012-13-10-r93 · Cited by 77 · see citing works

Transferrin-Conjugated Micelles: Enhanced Accumulation and Antitumor Effect for Transferrin-Receptor-Overexpressing Cancer Models

Yue, J., Liu, S., Wang, R., Hu, X., Xie, Z., Huang, Y., & Jing, X. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300213g · Cited by 77 · see citing works

Heavy Chain Ferritin siRNA Delivered by Cationic Liposomes Increases Sensitivity of Cancer Cells to Chemotherapeutic Agents

Liu, X., Madhankumar, A. B., Slagle‐Webb, B., Sheehan, J. M., Surguladze, N., & Connor, J. R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1375 · Cited by 76 · see citing works

Tachpyridine, a metal chelator, induces G2 cell-cycle arrest, activates checkpoint kinases, and sensitizes cells to ionizing radiation

Turner, J. (2005) · Blood · doi:10.1182/blood-2005-03-1263 · Cited by 76 · see citing works

Iron Deprivation Suppresses Hepatocellular Carcinoma Growth in Experimental Studies

Ba, Q., Hao, M., Huang, H., Hou, J., Ge, S., Zhang, Z., Yin, J., Chu, R., Jiang, H., Wang, F., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3099 · Cited by 75 · see citing works

Thyroid dysfunction associated with immunotherapy for patients with cancer

Schwartzentruber, D. J., White, D. E., ZWEIG, M. H., Weintraub, B. D., & Rosenberg, S. A. (1991) · Cancer · doi:10.1002/1097-0142(19911201)68:11 · Cited by 73 · see citing works

Relationships of lipocalin 2 with breast tumorigenesis and metastasis

Leng, X., Wu, Y., & Arlinghaus, R. B. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22403 · Cited by 72 · see citing works

Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies.

Taetle, R., Castagnola, J., & Mendelsohn, J. M. (1986) · PubMed · Cited by 71 · see citing works

Heme iron from meat and risk of adenocarcinoma of the esophagus and stomach

Ward, M. H., Cross, A. J., Abnet, C. C., Sinha, R. R., Markin, R. S., & Weisenburger, D. D. (2011) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e32834c9b6c · Cited by 71 · see citing works

Body Iron Stores and Mortality due to Cancer and Ischaemic Heart Disease: A 17-Year Follow-Up Study of Elderly Men and Women

van Asperen, I. A., Feskens, E. J. M., Bowles, C. H., & Kromhout, D. (1995) · International Journal of Epidemiology · doi:10.1093/ije/24.4.665 · Cited by 70 · see citing works

Modulation of Wnt/β-catenin signaling and proliferation by a ferrous iron chelator with therapeutic efficacy in genetically engineered mouse models of cancer

Coombs, G. S., Schmitt, A., Canning, C. A., Alok, A., Low, I. C. C., Banerjee, N., Kaur, S. J., Utomo, V., Jones, C. M., Pervaiz, S., et al. (2011) · Oncogene · doi:10.1038/onc.2011.228 · Cited by 69 · see citing works

Tumorigenic Properties of Iron Regulatory Protein 2 (IRP2) Mediated by Its Specific 73-Amino Acids Insert

Maffettone, C., Chen, G., Drozdov, I. A., Ouzounis, C. A., & Pantopoulos, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010163 · Cited by 68 · see citing works

Nephrotoxicity of ferric nitrilotriacetate. An electron-microscopic and metabolic study.

Hamazaki, S., Okada, S., Ebina, Y., et al. (1986) · PubMed · Cited by 62 · see citing works

Iron chelation therapy with deferasirox induced complete remission in a patient with chemotherapy-resistant acute monocytic leukemia.

Fukushima, T., Kawabata, H., Nakamura, T., et al. (2011) · PubMed · Cited by 62 · see citing works

Specific Allelic Loss of p16 Tumor Suppressor Gene after Weeks of Iron-Mediated Oxidative Damage during Rat Renal Carcinogenesis

Hiroyasu, M., Ozeki, M., Kohda, H., Echizenya, M., Tanaka, T., Hiai, H., & Toyokuni, S. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64860-2 · Cited by 61 · see citing works

Lipocalin2 Promotes Invasion, Tumorigenicity and Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma

Leung, L., Radulovich, N., Zhu, C., Organ, S. L., Bandarchi, B., Pintilie, M., To, C., Panchal, D., & Tsao, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046677 · Cited by 60 · see citing works

Effects of Precipitated Silica and of Iron Oxide on the Incidence of Primary Lung Tumours in Mice

Campbell, J. A. (1940) · BMJ · doi:10.1136/bmj.2.4156.275 · Cited by 60 · see citing works

Development of Human Single-Chain Antibodies to the Transferrin Receptor that Effectively Antagonize the Growth of Leukemias and Lymphomas

Crépin, R., Goenaga, A.-L., Jullienne, B., Bougherara, H., Legay, C., Benihoud, K., Marks, J. D., & Poul, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0938 · Cited by 59 · see citing works

Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6.

Brooks, D., Taylor, C. G., Santos, B. D., Linden, H. C. D. V., Houghton, A., Hecht, T. T., Kornfeld, S. A., & Taetle, R. (1995) · PubMed · Cited by 56 · see citing works

NGAL Expression Is Elevated in Both Colorectal Adenoma–Carcinoma Sequence and Cancer Progression and Enhances Tumorigenesis in Xenograft Mouse Models

Sun, Y. K., Yokoi, K., Li, H., Gao, J., Hu, L., Liu, B., Chen, K., Hamilton, S. R., Fan, D., Sun, B., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0226 · Cited by 55 · see citing works

Overexpression of iron regulatory protein 1 suppresses growth of tumor xenografts

Chen, G., Fillebeen, C., Wang, J., & Pantopoulos, K. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl210 · Cited by 55 · see citing works

Iron Withholding: A Defense Against Disease

Weinberg, E. D., & Judith Miklossy, A. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13409 · Cited by 53 · see citing works

NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification

Zhang, Y., Fan, Y., & Mei, Z. (2012) · Cancer Epidemiology · doi:10.1016/j.canep.2012.05.012 · Cited by 51 · see citing works

Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Response to Neoadjuvant Chemotherapy and Clinical Outcome in Primary Human Breast Cancer

Wenners, A. S., Mehta, K. M., Loibl, S., Park, H., Mueller, B., Arnold, N., Hamann, S., Weimer, J. P., Ataseven, B., Darb‐Esfahani, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045826 · Cited by 50 · see citing works

Chronic Oxidative Stress Causes Amplification and Overexpression of ptprz1 Protein Tyrosine Phosphatase to Activate β-Catenin Pathway

Liu, Y.-T., Shang, D., Akatsuka, S., Ohara, H., Dutta, K. K., Mizushima, K., Naito, Y., Yoshikawa, T., Izumiya, M., Abe, K., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070741 · Cited by 48 · see citing works

Ferritin expression modulates cell cycle dynamics and cell responsiveness to H-ras-induced growth via expansion of the labile iron pool

Kakhlon, O., Gruenbaum, Y., & Cabantchik, Z. I. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3630431 · Cited by 44 · see citing works

Preferential repression of the H subunit of ferritin by adenovirus E1A in NIH-3T3 mouse fibroblasts.

Tsuji, Y., Kwak, E. L., Saika, T., Torti, S. V., & Torti, F. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53172-0 · Cited by 43 · see citing works

2.6 Å X-ray Crystal Structure of Human p53R2, a p53-Inducible Ribonucleotide Reductase,

Smith, P., Zhou, B., Ho, N. N., Yuan, Y., Su, L., Tsai, S., & Yen, Y. (2009) · Biochemistry · doi:10.1021/bi9001425 · Cited by 43 · see citing works

Iron regulation of hepatic macrophage TNFα expression1,2 1Guest editor: Arthur Cederbaum 2This article is part of a series of reviews on “Alcohol, Oxidative Stress and Cell Injury.” The full list of papers may be found on the homepage of the journal.

Tsukamoto, H. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00772-9 · Cited by 43 · see citing works

A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study

Chao, J., Synold, T. W., Morgan, R. J., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1779-5 · Cited by 42 · see citing works

Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced Hamster Cheek Pouch Carcinogenesis by a 5-Lipoxygenase Inhibitor, Garcinol

Chen, X., Zhang, X., Lu, Y., et al. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.718032 · Cited by 40 · see citing works

Dietary Iron Promotes Azoxymethane-Induced Colon Tumors in Mice

Ilsley, J. N. M., Belinsky, G. S., Guda, K., Zhang, Q., Huang, X., Blumberg, J. B., Milbury, P. E., Roberts, L. J., Stevens, R. G., & Rosenberg, D. W. (2004) · Nutrition and Cancer · doi:10.1207/s15327914nc4902_7 · Cited by 40 · see citing works

Definition of the Roles for Iron and Essential Fatty Acids in Cell Cycle Progression of Normal Human T Lymphocytes

Terada, N., Or, R., Szepesi, Á., et al. (1993) · Experimental Cell Research · doi:10.1006/excr.1993.1032 · Cited by 40 · see citing works

Ferritin Blocks Inhibitory Effects of Two-Chain High Molecular Weight Kininogen (HKa) on Adhesion and Survival Signaling in Endothelial Cells

Tesfay, L., Huhn, A. J., Hatcher, H., Torti, F. M., & Torti, S. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040030 · Cited by 39 · see citing works

The Friedreich's ataxia protein frataxin modulates DNA base excision repair in prokaryotes and mammals

Thierbach, R., Drewes, G., Fußer, M., Voigt, A., Kuhlow, D., Blume, U., Schulz, T. J., Reiche, C., Glatt, H. R., Epe, B., et al. (2010) · Biochemical Journal · doi:10.1042/bj20101116 · Cited by 38 · see citing works

Targeting the Wnt/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model.

Kim, Y. H., Schmidt, M., Endo, T., et al. (2012) · PubMed · Cited by 37 · see citing works

Tyrosine phosphatase beta regulates angiopoietin-Tie2 signaling in human endothelial cells

Yacyshyn, O. K., Lai, P. F. H., Forse, K., Teichert-Kuliszewska, K., Jurasz, P., & Stewart, D. J. (2009) · Angiogenesis · doi:10.1007/s10456-008-9126-0 · Cited by 30 · see citing works

Dietary iron and haem iron intake and risk of endometrial cancer: a prospective cohort study

Kabat, G. C., Miller, A. B., Jain, M., & Rohan, T. E. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604110 · Cited by 30 · see citing works

Ferritin expression modulates cell cycle dynamics and cell responsiveness to H-ras-induced growth via expansion of the labile iron pool

Kakhlon, O., Gruenbaum, Y., & Cabantchik, Z. I. (2002) · Biochemical Journal · doi:10.1042/bj3630431 · Cited by 30 · see citing works

No Effect of NGAL/lipocalin-2 on Aggressiveness of Cancer in the MMTV-PyMT/FVB/N Mouse Model for Breast Cancer

Cramer, E. P., Glenthøj, A. B., Häger, M., Juncker‐Jensen, A., Engelholm, L. H., Santoni‐Rugiu, E., Lund, L. R., Lærum, O. D., Cowland, J. B., & Borregaard, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039646 · Cited by 28 · see citing works

The core control system of intracellular iron homeostasis: A mathematical model

Chifman, J., Kniss, A., Neupane, P., Williams, I., Leung, B., Deng, Z., Mendes, P., Hower, V., Torti, F. M., Akman, S. A., et al. (2012) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2012.01.024 · Cited by 28 · see citing works

Receptor-type Protein Tyrosine Phosphatase β (RPTP-β) Directly Dephosphorylates and Regulates Hepatocyte Growth Factor Receptor (HGFR/Met) Function

Xu, Y., Xia, W., Baker, D. K., Zhou, J., Cha, H. C., Voorhees, J. J., & Fisher, G. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.212597 · Cited by 26 · see citing works

Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes?

Carpagnano, G. E., Lacedonia, D., Palladino, G. P., Koutelou, A., Martinelli, D., Orlando, S., & Barbaro, M. P. F. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02603.x · Cited by 25 · see citing works

Repression of ferritin expression modulates cell responsiveness to H-ras-induced growth

Kakhlon, O., Gruenbaum, Y., & Cabantchik, Z. I. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300777 · Cited by 24 · see citing works

A Dose Escalation and Pharmacodynamic Study of Triapine and Radiation in Patients With Locally Advanced Pancreas Cancer

Martin, L. K., Grecula, J. C., Jia, G., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.06.003 · Cited by 23 · see citing works

Iron Stimulates Urokinase Plasminogen Activator Expression and Activates NF-kappa B in Human Prostate Cancer Cells

Ornstein, D. L., & Zacharski, L. R. (2007) · Nutrition and Cancer · doi:10.1080/01635580701308265 · Cited by 22 · see citing works

Deletion and single nucleotide substitution at G:C in the kidney of gpt delta transgenic mice after ferric nitrilotriacetate treatment

Jiang, L., 田中, 義., Akatsuka, S., Liu, Y., Dutta, K. K., Lee, W., Onuki, J., Masumura, K., Nohmi, T., & Toyokuni, S. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00301.x · Cited by 19 · see citing works

Differential gene expression in normal and transformed human mammary epithelial cells in response to oxidative stress

Cortes, D. F., Sha, W., Hower, V., Blekherman, G., Laubenbacher, R., Akman, S. A., Torti, S. V., & Shulaev, V. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.002 · Cited by 18 · see citing works

Gastric carcinoma in siblings with Friedreich's ataxia

Ackroyd, R., Shorthouse, A. J., & Stephenson, T. J. (1996) · European Journal of Surgical Oncology · doi:10.1016/s0748-7983(96)80023-0 · Cited by 14 · see citing works

Breast cancer in two sisters with Friedreich's ataxia

Kidd, A., Coleman, R. J., Whiteford, M., Barron, L. H., Simpson, S. A., & Haites, N. E. (2001) · European Journal of Surgical Oncology · doi:10.1053/ejso.2000.1093 · Cited by 13 · see citing works

ROS Are Good

Mittler, R. (2017) · Trends in Plant Science · doi:10.1016/j.tplants.2016.08.002 · Cited by 3,499 · see citing works

HSPB1 as a novel regulator of ferroptotic cancer cell death

Sun, X., Ou, Z., Xie, M., Kang, R., Fan, Y., Niu, X., Wang, H., Cao, L., & Tang, D. (2015) · Oncogene · doi:10.1038/onc.2015.32 · Cited by 666 · see citing works

Iron and cancer: recent insights

Manz, D. H., Blanchette, N. L., Paul, B. T., Torti, F. M., & Torti, S. V. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13008 · Cited by 507 · see citing works

Two Faces of Vitamin C—Antioxidative and Pro-Oxidative Agent

Kaźmierczak-Barańska, J., Boguszewska, K., Adamus-Grabicka, A., & Karwowski, B. T. (2020) · Nutrients · doi:10.3390/nu12051501 · Cited by 455 · see citing works

O2⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate

Schoenfeld, J. D., Sibenaller, Z. A., Mapuskar, K. A., Wagner, B. A., Cramer-Morales, K. L., Furqan, M., Sandhu, S., Carlisle, T. L., Smith, M. C., Abu Hejleh, T., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.018 · Cited by 443 · see citing works

Iron and Cancer

Torti, S. V., Manz, D. H., Paul, B. T., Blanchette-Farra, N., & Torti, F. M. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082117-051732 · Cited by 426 · see citing works

Targeting cancer vulnerabilities with high-dose vitamin C

Ngo, B., Van Riper, J. M., Cantley, L. C., & Yun, J. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0135-7 · Cited by 423 · see citing works

Lipocalin 2: an emerging player in iron homeostasis and inflammation

Xiao, X., Yeoh, B. S., & Vijay-Kumar, M. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064559 · Cited by 426 · see citing works

Antibody–drug conjugates: Recent advances in linker chemistry

Su, Z., Xiao, D., Xie, F., Liu, L., Wang, Y., Fan, S., Zhou, X., & Li, S. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.042 · Cited by 403 · see citing works

The IRP/IRE system in vivo: insights from mouse models

Wilkinson, N., & Pantopoulos, K. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00176 · Cited by 366 · see citing works

Targeting iron metabolism in drug discovery and delivery

Crielaard, B. J., Lammers, T., & Rivella, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.248 · Cited by 352 · see citing works

Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis.

Chi, Y., Remsik, J., Kiseliovas, V., Derderian, C., Sener, U., Alghader, M., Saadeh, F., Nikishina, K., Bale, T., Iacobuzio-Donahue, C., et al. (2020) · Science · doi:10.1126/science.aaz2193 · Cited by 320 · see citing works

NUPR1 is a critical repressor of ferroptosis

Liu, J., Song, X., Kuang, F., Zhang, Q., Xie, Y., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Communications · doi:10.1038/s41467-021-20904-2 · Cited by 290 · see citing works

The Role of Iron Regulation in Immunometabolism and Immune-Related Disease

Cronin, S. J. F., Woolf, C. J., Weiss, G., & Penninger, J. M. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00116 · Cited by 299 · see citing works

Oxidative Stress and the Homeodynamics of Iron Metabolism

Bresgen, N., & Eckl, P. (2015) · Biomolecules · doi:10.3390/biom5020808 · Cited by 247 · see citing works

Hepcidin regulation in prostate and its disruption in prostate cancer

Tesfay, L., Clausen, K. A., Kim, J. W., Hegde, P., Wang, X., Miller, L. D., Deng, Z., Blanchette, N., Arvedson, T., Miranti, C. K., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2465 · Cited by 186 · see citing works

Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancer

Chaudhary, N., Choudhary, B. S., Shah, S. G., Khapare, N., Dwivedi, N., Gaikwad, A., Joshi, N., Raichanna, J., Basu, S., Gurjar, M., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33711 · Cited by 185 · see citing works

Iron induces anti-tumor activity in tumor-associated macrophages

Costa da Silva, M., Breckwoldt, M. O., Vinchi, F., Correia, M. P., Stojanovic, A., Thielmann, C. M., Meister, M., Muley, T., Warth, A., Platten, M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01479 · Cited by 164 · see citing works

Multiomic spatial landscape of innate immune cells at human central nervous system borders

Sankowski, R., Süß, P., Benkendorff, A., Böttcher, C., Fernandez-Zapata, C., Chhatbar, C., Cahueau, J., Monaco, G., Gasull, A. D., Khavaran, A., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02673-1 · Cited by 156 · see citing works

Iron in the Tumor Microenvironment-Connecting the Dots

Pfeifhofer-Obermair, C., Tymoszuk, P., Petzer, V., Weiss, G., & Nairz, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00549 · Cited by 151 · see citing works

The Role of Iron in Cancer Progression

Guo, Q., Li, L., Hou, S., Yuan, Z., Li, C., Zhang, W., Zheng, L., & Li, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.778492 · Cited by 150 · see citing works

Increased virulence of the oral microbiome in oral squamous cell carcinoma revealed by metatranscriptome analyses

Yost, S., Stashenko, P., Choi, Y., Kukuruzinska, M., Genco, C. A., Salama, A., Weinberg, E. O., Kramer, C. D., & Frias-Lopez, J. (2018) · International Journal of Oral Science · doi:10.1038/s41368-018-0037-7 · Cited by 144 · see citing works

The Multifaceted Role of Heme in Cancer

Fiorito, V., Chiabrando, D., Petrillo, S., Bertino, F., & Tolosano, E. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01540 · Cited by 129 · see citing works

Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism

Rychtarcikova, Z., Lettlova, S., Tomkova, V., Korenkova, V., Langerova, L., Simonova, E., Zjablovskaja, P., Alberich-Jorda, M., Neuzil, J., & Truksa, J. (2017) · Oncotarget · doi:10.18632/oncotarget.14093 · Cited by 100 · see citing works

Co-delivery of Dihydroartemisinin and Pyropheophorbide-Iron Elicits Ferroptosis to Potentiate Cancer Immunotherapy

Han, W., Duan, X., Ni, K., Li, Y., Chan, C., & Lin, W. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2021.121315 · Cited by 103 · see citing works

Macrophage-derived lipocalin-2 transports iron in the tumor microenvironment

Mertens, C., Mora, J., Ören, B., Grein, S., Winslow, S., Scholich, K., Weigert, A., Malmström, P., Forsare, C., Fernö, M., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1408751 · Cited by 85 · see citing works

Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression

Mertens, C., Akam, E. A., Rehwald, C., Brüne, B., Tomat, E., & Jung, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166164 · Cited by 83 · see citing works

Fluorescent probes for the detection of catalytic Fe(II) ion

Hirayama, T. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.07.004 · Cited by 79 · see citing works

Dietary iron enhances colonic inflammation and IL-6/IL-11-Stat3 signaling promoting colonic tumor development in mice

Chua, A. C. G., Klopcic, B. R. S., Ho, D. S., Fu, S. K., Forrest, C. H., Croft, K. D., Olynyk, J. K., Lawrance, I. C., & Trinder, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078850 · Cited by 76 · see citing works

Iron and iron-dependent reactive oxygen species in the regulation of macrophages and fibroblasts in non-healing chronic wounds

Wlaschek, M., Singh, K., Sindrilaru, A., Crisan, D., & Scharffetter-Kochanek, K. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.036 · Cited by 76 · see citing works

The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma

Kamihara, Y., Takada, K., Sato, T., Kawano, Y., Murase, K., Arihara, Y., Kikuchi, S., Hayasaka, N., Usami, M., Iyama, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11830 · Cited by 45 · see citing works

An oxygen-dependent interaction between FBXL5 and the CIA-Targeting Complex Regulates Iron Homeostasis

Mayank, A. K., Pandey, V., Vashisht, A. A., Barshop, W. D., Rayatpisheh, S., Sharma, T., Haque, T., Powers, D. N., & Wohlschlegel, J. A. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.05.020 · Cited by 45 · see citing works

Asbestos conceives Fe(II)-dependent mutagenic stromal milieu through ceaseless macrophage ferroptosis and β-catenin induction in mesothelium

Ito, F., Yanatori, I., Maeda, Y., Nimura, K., Ito, S., Hirayama, T., Nagasawa, H., Kohyama, N., Okazaki, Y., Akatsuka, S., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101616 · Cited by 45 · see citing works

Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches

Cheng, X., Zhao, F., Ke, B., Chen, D., & Liu, F. (2023) · Cancers · doi:10.3390/cancers15215209 · Cited by 44 · see citing works

Contrasting intra- and extracellular distribution of catalytic ferrous iron in ovalbumin-induced peritonitis

Ito, F., Nishiyama, T., Shi, L., Mori, M., Hirayama, T., Nagasawa, H., Yasui, H., & Toyokuni, S. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.003 · Cited by 41 · see citing works

Iron alters cell survival in a mitochondria-dependent pathway in ovarian cancer cells

Bauckman, K., Haller, E., Taran, N., Rockfield, S., Ruiz-Rivera, A., & Nanjundan, M. (2015) · Biochemical Journal · doi:10.1042/bj20140878 · Cited by 41 · see citing works

Iron imaging reveals tumor and metastasis macrophage hemosiderin deposits in breast cancer

Leftin, A., Ben-Chetrit, N., Klemm, F., Joyce, J. A., & Koutcher, J. A. (2017) · PLOS ONE · doi:10.1371/journal.pone.0184765 · Cited by 36 · see citing works

A link between premenopausal iron deficiency and breast cancer malignancy

Jian, J., Yang, Q., Shao, Y., Axelrod, D., Smith, J., Singh, B., Krauter, S., Chiriboga, L., Yang, Z., Li, J., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-307 · Cited by 37 · see citing works

Iron deposition is associated with differential macrophage infiltration and therapeutic response to iron chelation in prostate cancer

Leftin, A., Zhao, H., Turkekul, M., de Stanchina, E., Manova, K., & Koutcher, J. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-11899-2 · Cited by 33 · see citing works

Ferrous iron–activatable drug conjugate achieves potent MAPK blockade in <i>KRAS</i> -driven tumors

Jiang, H., Muir, R. K., Gonciarz, R. L., Olshen, A. B., Yeh, I., Hann, B. C., Zhao, N., Wang, Y.-H., Behr, S. C., Korkola, J. E., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20210739 · Cited by 33 · see citing works

Iron Metabolism: State of the Art in Hypoxic Cancer Cell Biology

Liu, S., Cao, X., Wang, D., & Zhu, H. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109199 · Cited by 31 · see citing works

Unveiling ferroptosis as a promising therapeutic avenue for colorectal cancer and colitis treatment

Kao, A. T., Cabanlong, C. V., Padilla, K., & Xue, X. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.05.025 · Cited by 30 · see citing works

Investigating the real role of HIF-1 and HIF-2 in iron recycling by macrophages

Mathieu, J. R. R., Heinis, M., Zumerle, S., Delga, S., Le Bon, A., & Peyssonnaux, C. (2014) · Haematologica · doi:10.3324/haematol.2013.102319 · Cited by 22 · see citing works

Functional genomics and metabolomics advance the ethnobotany of the Samoan traditional medicine “matalafi”

Molimau-Samasoni, S., Woolner, V. H., Foliga, S. T., Robichon, K., Patel, V., Andreassend, S. K., Sheridan, J. P., Te Kawa, T., Gresham, D., Miller, D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100880118 · Cited by 20 · see citing works

Iron chelation promotes 5-aminolaevulinic acid-based photodynamic therapy against oral tongue squamous cell carcinoma

Qin, J., Zhou, C., Zhu, M., Shi, S., Zhang, L., Zhao, Y., Li, C., Wang, Y., & Wang, Y. (2020) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2020.101907 · Cited by 17 · see citing works

Wnt Signal Transduction and Its Biological Effects

Zhang, P. (2001) · Zhongguo shengwu huaxue yu fenzi shengwu xuebao

The Inhibition of Wnt Restrain KRASG12V-Driven Metastasis in Non-Small-Cell Lung Cancer

Hung, P.-S., Huang, M.-H., Kuo, Y., & Yang, J. C. (2020) · Cancers · doi:10.3390/cancers12040837 · Cited by 14 · see citing works

Cell‐cell signaling by direct contact increases cell proliferation via a PI3K‐dependent signal

Nelson, C. M., & Chen, C. S. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02370-0 · Cited by 264 · see citing works

WDR74 induces nuclear β-catenin accumulation and activates Wnt-responsive genes to promote lung cancer growth and metastasis

Li, Y., Chen, F., Shen, W., Li, B., Xiang, R., Qu, L., Zhang, C., Gao, L., Xie, H., Katanaev, V. L., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.12.011 · Cited by 34 · see citing works

β-Arrestin1 Promotes Colorectal Cancer Metastasis Through GSK-3β/β-Catenin Signaling- Mediated Epithelial-to-Mesenchymal Transition

Song, Q., Han, Z., Wu, X., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.650067 · Cited by 13 · see citing works